a variety of nematodes and is the drug of choice for STRONGYLOIDIASIS. It has CENTRAL NERVOUS SYSTEM side effects and hepatototoxic potential. (From Smith and Reynard, Textbook of Pharmacology, 1992, p919)
Thiabendazole has been studied across 13 research domains including 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🔬 Oncology, 😴 Sleep, 🫘 Kidney. The primary research focus is 🫁 Liver & Detox with 6% of studies addressing this area.
The following compounds share molecular targets with Thiabendazole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Thiabendazole is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.